2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.
Regulaxis is proud to present the recent results on the effectiveness of REG-O3 in a model of traumatic knee osteoarthitis.
Recent Comments
Categories
-
-
2019 – Toronto, Canada – OARSI World CongressMay 2nd, 2019 -
-
A new hope for OsteoArthritic patientsJune 1st, 2021
-
2020 – BioJapan ExpoJuly 27th, 2020
-
2020 – B SMART – SMALL IS SMARTJuly 7th, 2020
-
PLOS ONE – PublicationJuly 3rd, 2020
-
2019 – Vancouver, Canada – 15th World Congress of ICRSJuly 3rd, 2020
-
2019 – Regulaxis et BiocitechOctober 22nd, 2019
-
2019 – Le Figaro Economie – RDV PMEJuly 10th, 2019 -
2019 – Sendai, Japan – EU-Japan Industrial CooperationMay 30th, 2019 -
-
2019 – Toronto, Canada – OARSI World CongressMay 2nd, 2019
-
2019 – Paris, France – ANRT – CLUB PME – ETIApril 8th, 2019
-
2018 – Regulaxis moves to La Défense !December 10th, 2018
-
2018 – Partnership between REGULAXIS and ARTIALISJune 15th, 2018 -
2018 – Liverpool – OARSI World Congress on OsteoarthritisApril 26th, 2018 -
2018 – Macau, China – 14th World Congress of ICRSApril 9th, 2018
-
REGULAXIS awarded from EU HORIZON 2020 PROGRAM !May 1st, 2017 -
2016 – Romainville, France – BIOCITECHDAYJune 28th, 2016 -
2015 – Paris, France – I-LAB 2015July 1st, 2015
-
REGULAXIS – Un nouveau traitement de l’arthrose (by Fundme)October 17th, 2014
Leave A Comment